Ethnic variation in return to baseline values of patient-reported outcomes in older prostate cancer patients

Cancer

Volumn 109, Issue 11, 2007, Pages 2229-2238

  Jayadevappa, Ravishankar ^a   Johnson, Jerry C ^a   Chhatre, Surnedha ^a   Wein, Alan J ^a   Malkowicz, S Bruce ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Clinically important difference; Ethnicity; Health related quality of life; Minimally important difference; Older; Patient reported outcome; Satisfaction with care

Indexed keywords

AFRICAN AMERICAN; AGED; ARTICLE; BLADDER CANCER; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; COHORT ANALYSIS; EMOTION; ETHNIC DIFFERENCE; EUROPEAN AMERICAN; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MARRIAGE; MICTURITION; OBSERVATIONAL STUDY; PAIN; PATIENT SATISFACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATECTOMY; QUALITY OF LIFE; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; AFRICAN AMERICANS; AGED; COHORT STUDIES; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; HEALTH STATUS; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; SELF DISCLOSURE;

EID: 34249097462     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22675     Document Type: Article

References (40)

1. Cancer facts and figures 2006. Atlanta: American Cancer Society; 2006. Available from http://www.cancer.org.
2. Shavers VL, Brown ML, Potosky AL, et al. Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer. J Gen Intern Med. 2004;19:146-155.
3. Lubeck DP, Kim H, Grossfeld G, et al. Health related quality of life differences between black and white men with prostate cancer: data from the cancer of the prostate strategic urologic research endeavor. J Urol. 2001;166:2281-2285.
4. Comment in: J Urol. 2001;166:2291-2292.
5. Schapira MM, Mcauliffe TL, Nattinger BA. Treatment of localized prostate cancer in African-American compared with Caucasian men. Medical Care. 1995;33:1079-1088.
6. Harlan L, Brawley O, Pommerenke F, Wali P, Kramer B. Geographic, age, and racial variation in the treatment of Local/Regional Carcinoma of the prostate. J Clin Oncol. 1995;13:93-100.
7. Comment in: J Clin Oncol. 1995;13:1823.
8. Freedland SJ, Isaacs WB. Explaining racial differences in prostate cancer in the United States: sociology or biology? Prostate. 2005;62:243-252.
9. Young CD, Roach M III. Race and prostate cancer: what do we know? Prostate J. 2000;2:33-41.
10. Underwood W, De Monner S, Ubel P, Fagerlin A, Sanda MG, Wei JT. Racial/ethnic disparities in the treatment of localized/regional prostate cancer. J Urol. 2004;171:1504-1507.
11. Comment in: J Urol. 2004;172(4 pt 1):1547-1548; author reply 1548.
12. Ko YJ, Bubley GJ. Prostate cancer in the older man. Oncology (Williston Park). 2001;15:1113-1119, 1123-1124; discussion 1124-1126, 1131.
13. Pienta KJ, Demers R, Hoff M, Kau TY, Montie JE, Severson RK. Effect of age and race on the survival of men with prostate cancer in Metropolitan Detroit tricounty area, 1973-1987. Urology. 1995;45:93-101; discussion 101-102.
14. Johnson TK, Gilliland FD, Hoffman RM, et al. Racial/ethnic differences in functional outcomes in the 5 years after diagnosis of localized prostate cancer. J Clin Oncol. 2004; 22:4193-4201.
15. Klabunde CN, Potosky AL, Harlan LC, Kramer BS. Trends and black/white differences in treatment for nonmetastatic prostate cancer. Med Care. 1998;36:1337-1348.
16. Pettaway CA, Troncoso P, Ramirez EI, Johnston DA, Steelhammer L, Babaian RJ. Prostate specific antigen and pathological features of prostate cancer in black and white patients: A comparative study based on radical prostatectomy specimens. J Urol. 1998;160:437-442.
17. Comment in: J Urol. 1998160:443-444.
18. McNaughton-Collins M, Walker-Corkery E, Barry MJ. Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000. J Natl Cancer Inst Monogr. 2004; 33:78-101.
19. Mulley AG, Barry MJ. Controversy in managing patients with prostate cancer. Banish dogma, get more data. BMJ. 1998;316:1919-1920.
20. Comment in: BMJ. 1999;318:126.
21. Alibhai SM, Naglie G, Nam R, Trachtenberg J, Krahn MD. Do older men benefit from curative therapy of localized prostate cancer? J Clin Oncol. 2003;21:3318-3327.
22. Talcott JA, Clark JA. Quality of Life in prostate cancer. Eur J Cancer. 2005;41:922-931.
23. Chan JM, Jou RM, Carroll PR. The relative impact and future burden of prostate cancer in the United States. J Urol. 2004;172(5 pt 2):S13-S16; discussion S17.
24. Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Brook RH. The UCLA Prostate Cancer Index: development, reliability, and validity of health-related quality of life measure. Med Care. 1998;36:1002-1012.
25. Ware JE Jr, Sherbourne CD. The MOS 36-item short-for health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473-483.
26. Oliver RL. Satisfaction: a behavioral perspective on the consumer. New York: McGraw-Hill; 1997.
27. Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD. Assessment of Client/patient satisfaction: development of general scale. Eval Program Plan. 1979;2:197-207.
28. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
29. Wyrwich KW, Tierney WM, Babu AN, Kroenke K, Wolinsky FD. A comparison of clinically important differences in health-related quality of life for patients with chronic lung disease, asthma, or heart disease. Health Serv Res. 2005;40:577-591.
30. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003; 41:582-592.
31. Robbins AS, Whittemore AS, Van Den Eeden SK. Race, prostate cancer survival, and membership in a large health maintenance organization. J Natl Cancer Inst. 1998;90: 986-990.
32. Comment in: J Natl Cancer Inst. 1999;91:801-803.
33. Polednak AP. Prostate cancer treatment in black and white men: the need to consider both stage at diagnosis and socioeconomic status. J Natl Med Assoc. 1998;90:101-104.
34. Imperato PJ, Nenner RP, Will TO. Radical prostatectomy: Lower rates among African-American men. J Natl Med Assoc. 1996;88:589-594.
35. Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94: 334-357.
36. Denberg TD, Beaty BL, Kim FJ, Steiner JF. Marriage and ethnicity predict treatment in localized carcinoma. Cancer. 2005;103:1819-1825.
37. Knight SJ, Siston AM, Chmiel JS, et al. Ethnic variation in localized prostate cancer: a pilot study of preferences, optimism, and quality of life among black and white veterans. Clin Prostate Cancer. 2004;3:31-37.
38. Penedo FJ, Dann JR, Shen BJ, Schneiderman N, Antoni MH. Ethnicity and determinants of quality of life after prostate cancer treatment. Urology. 2006;67:1022-1027.
39. Campbell LC, Keefe FJ, McKee DC, et al. Prostate cancer in African Americans: relationship of patients and partner self-efficacy to quality of life. J Pain Symptom Manage. 2004;28:433-444.
40. Hoffman RM, Hunt WC, Gilliland FD, Stephenson RA, Potosky AL. Patient satisfaction with treatment decisions for clinically localized prostate carcinoma. Results from the Prostate Cancer Outcomes Study. Cancer. 2003;97:1653-62.